Skip to main content
. 2022 Mar 11;23:237. doi: 10.1186/s12891-022-05188-x

Table 3.

3, 6, and 12 month results in unadjusted and adjusted models comparing the intervention group to the nonparticipant group (reference)

Primary Outcome Timepoint Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value
 Pain (MCID) 3 months 1.72 (1.21, 2.42) 1.97 (1.28, 3.02) 0.002
6 months 1.62 (1.08, 2.38) 1.44 (0.91, 2.25) 0.113
12 months 1.97 (1.37, 2.82) 2.06 (1.38, 3.08) 0.004
Secondary Outcome
 Function (MCID) 3 months 1.67 (1.20, 2.33) 1.56 (1.03, 2.38) 0.010
6 months 1.84 (1.30, 2.63) 1.55 (1.02, 2.37) 0.041
12 months 1.14 (0.80, 1.61) 1.35 (0.89, 2.06) 0.160
 Moderate or severe depression 3 months 0.41 (0.25, 1.43) 0.27 (0.12, 0.60) 0.002
6 months 0.33 (0.19, 0.62) 0.41 (0.18, 0.91) 0.026
12 months 0.40 (0.24, 0.70) 0.35 (0.19, 0.65) 0.001
 Moderate or severe anxiety 3 months 0.34 (0.21, 1.80) 0.21 (0.09, 0.43) < 0.001
6 months 0.22 (0.13, 0.37) 0.15 (0.07, 0.31) < 0.001
12 months 0.48 (0.29, 0.80) 0.34 (0.19, 0.61) < 0.001